Skip Navigation



Family Practice Advance Access published online on November 1, 2009

Family Practice, doi:10.1093/fampra/cmp071
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Martín-Merino, E.
Right arrow Articles by García-Rodríguez, L. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martín-Merino, E.
Right arrow Articles by García-Rodríguez, L. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.

Prevalence, incidence, morbidity and treatment patterns in a cohort of patients diagnosed with anxiety in UK primary care

Elisa Martín-Merinoa, Ana Ruigómeza, Mari-Ann Wallanderb, Saga Johanssonc,d and Luis Alberto García-Rodrígueza

a Centro Español de Investigación Farmacoepidemiológica, Almirante 28 (2°), Madrid 28004, Spain
b Department of Public Health and Caring Sciences, Uppsala University, Uppsala Science Park, Uppsala S-751 83
c AstraZeneca R&D Mölndal, Mölndal S-431 83
d Institute of Medicine, Sahlgrenska Academy, Medicinaregatan 3, PO Box 400, Gothenburg SE 405 30, Sweden

Correspondence to Elisa Martín-Merino, Centro Español de Investigación Farmacoepidemiológica, Almirante 28 (2°), Madrid 28004, Spain; E-mail: elisaceife{at}telefonica.net


   Abstract

Background. Anxiety disorders are common and can cause substantial quality of life impairment.

Objective. The aim of this study was to investigate the frequency of anxiety in UK primary care. Treatment patterns and factors associated with an anxiety diagnosis were also assessed.

Methods. The Health Improvement Network was used to identify all patients aged 10–79 years with a new diagnosis of anxiety in 2002–04 (n = 40 873) and age-, sex- and calendar-year-matched controls (n = 50 000). A nested case–control analysis was used to quantify potential risk factors for anxiety by multivariate logistic regression.

Results. The prevalence of anxiety was 7.2% and the incidence was 9.7 per 1000 person-years. Incidence and prevalence were highest in women and young adults (20–29 years). Anxiety was associated with heavy alcohol use, smoking and addiction problems as well as stress, sleep and depression disorders. Anxiety patients used health care services more frequently than controls. Among patients diagnosed with anxiety, 63% were treated pharmacologically. Antidepressants accounted for almost 80% of prescriptions.

Conclusions. The prevalence and incidence of anxiety are high in UK primary care and are almost twice as high in women than in men. Anxiety is associated with other psychiatric morbidity as well as frequent health care use. Antidepressants are the most commonly used pharmacological treatment.

Keywords. Anxiety disorders, epidemiology, incidence, prevalence, primary health care.


Martín-Merino E, Ruigómez A, Wallander M-A, Johansson S and García-Rodríguez LA. Prevalence, incidence, morbidity and treatment patterns in a cohort of patients diagnosed with anxiety in UK primary care. Family Practice 2009; Pages 1–8 of 8.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.